Johnson and Johnson

Animas’ Response to FDA Insulin Pump Charges

By AmyT on February 1, 2012

Many of you have probably heard by now that J&J Animas was hit with a warning letter from FDA recently, and the accusations that they compromised patient safety by continuing to sell insulin pumps with known defects. This sounds pretty scary and negligent indeed. Why would a leading pump company do something so seemingly stupid? We called Animas spokesperson Caroline Pavis to get their side of the story.
Of course it’s the job of the company’s PR…

Read more »

A Peek Behind the Curtains at Animas: How One Pharma Co. is Working to “Engage” Online

By AmyT on November 11, 2010

Many of us patient advocates who make the rounds at e-patient and health 2.0 conferences hear an awful lot of talk about “what the patient wants” and how Pharma and device companies should reach out to our communities online.  Meanwhile, they’ve been slow to embrace Social Media, and given the controversy over FDA regulations for this, who knows what’s happening internally at these companies as they struggle to form a viable strategy for getting involved?…

Read more »